Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip

Mansoureh Z. Mousavi, Huai Yi Chen, Kuang Li Lee, Heng Lin, Hsi Hsien Chen, Yuh Feng Lin, Chung Shun Wong, Hsiao Fen Li, Pei Kuen Wei, Ji Yen Cheng

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Successful diagnosis and treatment of many diseases depends on the availability of sensitive, reliable and low cost tools for the detection of the biomarkers associated with the diseases. Simple methods that use non-invasive biological samples are especially suitable for the deployment in the clinical environment. In this paper we demonstrate the application of a method that employs a capped gold nanoslit surface plasmon resonance (SPR) sensor and a microfluidic chip for the detection of a urinary nucleic acid biomarker in clinical samples. This method detects low concentrations of the biomarker in a relatively large volume (∼1 mL) of the sample. The method utilizes magnetic nanoparticles (MNPs) for the isolation of target molecules and signal enhancement in conjunction with surface plasmon resonance (SPR) on capped gold nanoslits. The ability of the method to detect urinary miRNA-16-5p in AKI patients was tested and the result was compared with the data obtained with the polymerase chain reaction (PCR). miRNA-16-5p has been found to be a specific and noninvasive biomarker for acute kidney injury (AKI). Our method allows the detection of the biomarker in the urine of AKI patients without amplification and labeling of the target molecules.

Original languageEnglish
Pages (from-to)4097-4104
Number of pages8
JournalAnalyst
Volume140
Issue number12
DOIs
Publication statusPublished - Jun 21 2015

Fingerprint

Microfluidics
Surface Plasmon Resonance
Surface plasmon resonance
Biomarkers
RNA
MicroRNAs
Gold
biomarker
gold
Acute Kidney Injury
magnetic method
Molecules
Polymerase chain reaction
Nucleic acids
nucleic acid
urine
Labeling
Nucleic Acids
polymerase chain reaction
Amplification

ASJC Scopus subject areas

  • Analytical Chemistry
  • Spectroscopy
  • Electrochemistry
  • Biochemistry
  • Environmental Chemistry

Cite this

Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip. / Mousavi, Mansoureh Z.; Chen, Huai Yi; Lee, Kuang Li; Lin, Heng; Chen, Hsi Hsien; Lin, Yuh Feng; Wong, Chung Shun; Li, Hsiao Fen; Wei, Pei Kuen; Cheng, Ji Yen.

In: Analyst, Vol. 140, No. 12, 21.06.2015, p. 4097-4104.

Research output: Contribution to journalArticle

Mousavi, MZ, Chen, HY, Lee, KL, Lin, H, Chen, HH, Lin, YF, Wong, CS, Li, HF, Wei, PK & Cheng, JY 2015, 'Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip', Analyst, vol. 140, no. 12, pp. 4097-4104. https://doi.org/10.1039/c5an00145e
Mousavi, Mansoureh Z. ; Chen, Huai Yi ; Lee, Kuang Li ; Lin, Heng ; Chen, Hsi Hsien ; Lin, Yuh Feng ; Wong, Chung Shun ; Li, Hsiao Fen ; Wei, Pei Kuen ; Cheng, Ji Yen. / Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip. In: Analyst. 2015 ; Vol. 140, No. 12. pp. 4097-4104.
@article{c133947de83648678d419b010472ee74,
title = "Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip",
abstract = "Successful diagnosis and treatment of many diseases depends on the availability of sensitive, reliable and low cost tools for the detection of the biomarkers associated with the diseases. Simple methods that use non-invasive biological samples are especially suitable for the deployment in the clinical environment. In this paper we demonstrate the application of a method that employs a capped gold nanoslit surface plasmon resonance (SPR) sensor and a microfluidic chip for the detection of a urinary nucleic acid biomarker in clinical samples. This method detects low concentrations of the biomarker in a relatively large volume (∼1 mL) of the sample. The method utilizes magnetic nanoparticles (MNPs) for the isolation of target molecules and signal enhancement in conjunction with surface plasmon resonance (SPR) on capped gold nanoslits. The ability of the method to detect urinary miRNA-16-5p in AKI patients was tested and the result was compared with the data obtained with the polymerase chain reaction (PCR). miRNA-16-5p has been found to be a specific and noninvasive biomarker for acute kidney injury (AKI). Our method allows the detection of the biomarker in the urine of AKI patients without amplification and labeling of the target molecules.",
author = "Mousavi, {Mansoureh Z.} and Chen, {Huai Yi} and Lee, {Kuang Li} and Heng Lin and Chen, {Hsi Hsien} and Lin, {Yuh Feng} and Wong, {Chung Shun} and Li, {Hsiao Fen} and Wei, {Pei Kuen} and Cheng, {Ji Yen}",
year = "2015",
month = "6",
day = "21",
doi = "10.1039/c5an00145e",
language = "English",
volume = "140",
pages = "4097--4104",
journal = "The Analyst",
issn = "0003-2654",
publisher = "Royal Society of Chemistry",
number = "12",

}

TY - JOUR

T1 - Urinary micro-RNA biomarker detection using capped gold nanoslit SPR in a microfluidic chip

AU - Mousavi, Mansoureh Z.

AU - Chen, Huai Yi

AU - Lee, Kuang Li

AU - Lin, Heng

AU - Chen, Hsi Hsien

AU - Lin, Yuh Feng

AU - Wong, Chung Shun

AU - Li, Hsiao Fen

AU - Wei, Pei Kuen

AU - Cheng, Ji Yen

PY - 2015/6/21

Y1 - 2015/6/21

N2 - Successful diagnosis and treatment of many diseases depends on the availability of sensitive, reliable and low cost tools for the detection of the biomarkers associated with the diseases. Simple methods that use non-invasive biological samples are especially suitable for the deployment in the clinical environment. In this paper we demonstrate the application of a method that employs a capped gold nanoslit surface plasmon resonance (SPR) sensor and a microfluidic chip for the detection of a urinary nucleic acid biomarker in clinical samples. This method detects low concentrations of the biomarker in a relatively large volume (∼1 mL) of the sample. The method utilizes magnetic nanoparticles (MNPs) for the isolation of target molecules and signal enhancement in conjunction with surface plasmon resonance (SPR) on capped gold nanoslits. The ability of the method to detect urinary miRNA-16-5p in AKI patients was tested and the result was compared with the data obtained with the polymerase chain reaction (PCR). miRNA-16-5p has been found to be a specific and noninvasive biomarker for acute kidney injury (AKI). Our method allows the detection of the biomarker in the urine of AKI patients without amplification and labeling of the target molecules.

AB - Successful diagnosis and treatment of many diseases depends on the availability of sensitive, reliable and low cost tools for the detection of the biomarkers associated with the diseases. Simple methods that use non-invasive biological samples are especially suitable for the deployment in the clinical environment. In this paper we demonstrate the application of a method that employs a capped gold nanoslit surface plasmon resonance (SPR) sensor and a microfluidic chip for the detection of a urinary nucleic acid biomarker in clinical samples. This method detects low concentrations of the biomarker in a relatively large volume (∼1 mL) of the sample. The method utilizes magnetic nanoparticles (MNPs) for the isolation of target molecules and signal enhancement in conjunction with surface plasmon resonance (SPR) on capped gold nanoslits. The ability of the method to detect urinary miRNA-16-5p in AKI patients was tested and the result was compared with the data obtained with the polymerase chain reaction (PCR). miRNA-16-5p has been found to be a specific and noninvasive biomarker for acute kidney injury (AKI). Our method allows the detection of the biomarker in the urine of AKI patients without amplification and labeling of the target molecules.

UR - http://www.scopus.com/inward/record.url?scp=84930748548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930748548&partnerID=8YFLogxK

U2 - 10.1039/c5an00145e

DO - 10.1039/c5an00145e

M3 - Article

C2 - 25891475

AN - SCOPUS:84930748548

VL - 140

SP - 4097

EP - 4104

JO - The Analyst

JF - The Analyst

SN - 0003-2654

IS - 12

ER -